Microencapsulated vitamin tablets with enhanced delivery and reduced side effects
A novel formulation of vitamin tablets using pH-sensitive GRAS polymers to enhance delivery and minimize gastrointestinal side effects, such as stomachache and nausea, by preventing release in the stomach.
Overview
This innovative solution involves the development of vitamin tablets using microencapsulation techniques with pH-sensitive Generally Recognized As Safe (GRAS) polymers. The primary objective is to enhance the consumer experience by minimizing common gastrointestinal side effects, such as stomachache, nausea, and occasional vomiting, often associated with vitamin intake. By ensuring the vitamins are not released in the gastric environment but rather in the intestinal tract, the formulation aims to improve user comfort and compliance.
Technical specifications
The tablets are designed with a coating of GRAS polymers that remain stable in the acidic environment of the stomach but dissolve once they reach the more neutral pH of the intestines. This targeted release mechanism ensures that the vitamins are absorbed where they can be most effective, reducing the likelihood of irritation and discomfort. The development process includes formulation, manufacturing, and in vitro dissolution testing, with a comprehensive clinical study planned to confirm the benefits.
Technology readiness level
Currently at Technology Readiness Level 4, this technology has been validated in a laboratory setting with the next steps involving further formulation and manufacturing processes. A clinical study conducted by the sponsor will be necessary to validate the anticipated benefits and to advance this solution towards commercial viability.
About University of Minnesota
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.
delivered to your inbox.